Cita APA

Benkert, T. F., Dietz, L., Hartmann, E. M., Leich, E., Rosenwald, A., Serfling, E., . . . Berberich-Siebelt, F. (2012). Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis. Public Library of Science.

Chicago Style Citation

Benkert, Thomas F., Lena Dietz, Elena M. Hartmann, Ellen Leich, Andreas Rosenwald, Edgar Serfling, Mathias Buttmann, i Friederike Berberich-Siebelt. Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients With Multiple Sclerosis. Public Library of Science, 2012.

Cita MLA

Benkert, Thomas F., et al. Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients With Multiple Sclerosis. Public Library of Science, 2012.

Atenció: Aquestes cites poden no estar 100% correctes.